Barbara Dalton is the Head of Venture Capital at Pfizer. She is responsible for leading Pfizer's investments in early-stage biotech companies. Barbara Dalton has made significant investments in Artios Pharma, a company with a strong focus on advancing groundbreaking innovations in the field of oncology. Her investment highlights her dedication to supporting cutting-edge research and development efforts aimed at revolutionizing cancer treatments and improving patient outcomes.